Index Catalog // Hyrax

Remover filtros

Filtragem por: Coleção 55th Annual Duke School of Medicine Student Research Symposium Study Program Molecular Medicine Study Program (MolMed)

1. PCSK9 Inhibition Enhances Efficacy of Vemurafenib in Delaying Melanoma Tumor Growth

Descrição:: Background BRAF mutations are common in melanoma, with more than 50% harboring activating BRAF mutations. Though BRAF inhibitors are highly efficacious for nearly half of patients with this BRAF-mutant melanoma, many developing secondary resistance...
Data Criada:: August 1-2, 2024

2. Beta-blocker use and hematopoietic stem cell transplant outcomes

Descrição:: Background: While hematopoietic stem cell transplantation (HSCT) is an effective treatment for hematological malignancies, it is associated with several potential complications. Recent studies have associated beta-blocker (BB) use in critical care...
Data Criada:: August 1-2, 2024